Puma Biotechnology, Inc.
PBYI
$8.83
$0.121.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 56.50M | 44.81M | 75.45M | 54.48M | 52.44M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 56.50M | 44.81M | 75.45M | 54.48M | 52.44M |
| Cost of Revenue | 12.48M | 10.42M | 23.13M | 12.17M | 12.30M |
| Gross Profit | 44.03M | 34.39M | 52.33M | 42.30M | 40.14M |
| SG&A Expenses | 17.55M | 18.42M | 18.38M | 16.82M | 18.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.92M | 48.64M | 58.35M | 44.90M | 45.80M |
| Operating Income | 7.59M | -3.83M | 17.11M | 9.57M | 6.64M |
| Income Before Tax | 8.25M | -3.43M | 17.11M | 9.24M | 6.17M |
| Income Tax Expenses | 56.00K | 326.00K | 3.67M | 399.00K | 310.00K |
| Earnings from Continuing Operations | 8.19M | -3.75M | 13.44M | 8.84M | 5.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.19M | -3.75M | 13.44M | 8.84M | 5.86M |
| EBIT | 7.59M | -3.83M | 17.11M | 9.57M | 6.64M |
| EBITDA | 10.10M | -1.24M | 18.96M | 12.30M | 9.40M |
| EPS Basic | 0.16 | -0.07 | 0.27 | 0.18 | 0.12 |
| Normalized Basic EPS | 0.10 | -0.04 | 0.21 | 0.11 | 0.08 |
| EPS Diluted | 0.16 | -0.07 | 0.26 | 0.17 | 0.12 |
| Normalized Diluted EPS | 0.10 | -0.04 | 0.21 | 0.11 | 0.08 |
| Average Basic Shares Outstanding | 50.94M | 50.85M | 50.34M | 50.34M | 49.70M |
| Average Diluted Shares Outstanding | 52.60M | 50.85M | 51.52M | 50.93M | 50.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |